Search

everythinglearnresearchcommunity

for

Search:↓

Androgen conjugates might be better indicators of skin sensitivity to hormones in women with excessive hair growth.

Women with regular menstrual cycles and PCOS have linked kisspeptin and LH hormone patterns, unlike those with irregular cycles.

Female pattern hair loss diagnosed by scalp appearance, treated with combined therapies and targeted approaches.

Neurosteroids change how GABA_A receptors work in the brain, which could be important for treating temporal lobe epilepsy.

Low testosterone and 5α-reductase inhibitors can harm men's metabolic and sexual health; testosterone therapy may help, but discussing 5α-RIs' side effects is important.

Neuroactive steroids could become safe, effective treatments with more understanding of their complex brain actions and metabolism.

LPA3 is crucial for embryo implantation and links LPA to prostaglandin signaling.

Researchers found genetic mutations causing hypohidrotic ectodermal dysplasia in 88% of studied patients and identified new mutations and genetic variations affecting the disease.

Skin aging is caused by stem cell damage and can potentially be delayed with treatments like antioxidants and stem cell therapy.

Lovastatin doesn't improve lower urinary tract symptoms treatment.

Aldactone was more effective in reducing hair growth in women with hirsutism than Diane, despite having less impact on hormone levels.

Most treatments for hair loss in 1997 were not effective for most people, and maintaining hair growth was difficult.

Advancements in male reproductive medicine are ongoing, but more research and improved treatments are needed in several areas.

Selective Androgen Receptor Modulators (SARMs) are drugs that can control the effects of androgens in different tissues, potentially having fewer side effects and promising for treating various conditions.

The (+) enantiomer of YH239-EE effectively kills breast cancer cells.

Alternative treatments show promise for hair growth beyond traditional methods.

The conclusion is that young women with excessive hair growth should be quickly tested for hormonal issues and treated to improve their social well-being.

Certain gene variations are linked to higher male hormone levels in Chinese women with PCOS and insulin resistance.

The Androgen Receptor could be a target for treating diseases like cancer, but more research is needed to confirm the effectiveness of potential treatments.

5α-reductase inhibitors like finasteride may not be effective or safe for transgender individuals, and more research is needed.

Higher DHT in male baldness may protect against prostate cancer.

The article suggests that the belief in common postpartum hair loss lacks sufficient evidence and may be overestimated.

The article concludes that different types of hair loss require specific treatments and psychological support is important.

Finasteride helps reduce heart enlargement in heart failure patients.

Testosterone changes important cell communication proteins in pregnant rats' uteruses, which might affect pregnancy success.

Nanoparticles can be used to deliver drugs to hair follicles, potentially improving treatments for conditions like acne and alopecia, and could also be used for vaccine delivery and gene therapy.

The review concludes that more research is needed to better improve the health outcomes for people with Polycystic Ovarian Syndrome.

Molecular diagnostics help identify genetic defects causing endocrine diseases, improving diagnosis and treatment options.

AGA, a common hair loss, is caused by genetics, hormones, age, and environmental factors.

Formononetin, found in red clover, may treat hair loss with fewer side effects.